In mice with TB, treatment with a recombinant OX40 ligand enhanced the protective effects of BCG vaccination44,45, and OX40 deficient mice had a modest though statistically significant reduction in survival after Mtb infection40. This evidence concerns the gene TNFRSF4 and tuberculosis.